Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective

Robert C Rintoul; Matthew J Glover; Christopher Jackson; Victoria Hughes; Kurt G Tournoy; Christophe Dooms; Jouke T Annema; Linda D Sharples

doi:10.1136/thoraxjnl-2013-204374

Article info

Chest clinic

Audit, research and guideline update

Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective

Authors

Robert C Rintoul Department of Thoracic Oncology, Papworth Hospital, Cambridge, UK PubMed articles Google scholar articles
Matthew J Glover Health Economics Research Group, Brunel University, Middlesex, UK PubMed articles Google scholar articles
Christopher Jackson MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK PubMed articles Google scholar articles
Victoria Hughes Department of Thoracic Oncology, Papworth Hospital, Cambridge, UK PubMed articles Google scholar articles
Kurt G Tournoy Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium Department of Respiratory Medicine, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium PubMed articles Google scholar articles
Christophe Dooms Department of Respiratory Medicine, University of Leuven, Leuven, Belgium PubMed articles Google scholar articles
Jouke T Annema Department of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands Department of Pulmonology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands PubMed articles Google scholar articles
Linda D Sharples Department of Thoracic Oncology, Papworth Hospital, Cambridge, UK MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK Clinical Trials Research Unit, University of Leeds, Leeds, UK PubMed articles Google scholar articles

Correspondence to Prof Linda Sharples, MRC Biostatistics Unit Cambridge, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge CB2 0SR, UK; linda.sharples{at}mrc-bsu.cam.ac.uk

View Full Text

Citation

Rintoul RC, Glover MJ, Jackson C, et al

Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective

Thorax 2014;69:679-681.

Publication history

Received August 19, 2013
Accepted September 5, 2013
First published September 24, 2013.

Online issue publication

September 01, 2022

Article Versions

Previous version (29 April 2016).
You are viewing the most recent version of this article.

View clinical trial registration.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password